338 related articles for article (PubMed ID: 30759860)
41. Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma.
Yin VT; Esmaeli B
Curr Pharm Des; 2017; 23(4):655-659. PubMed ID: 27928965
[TBL] [Abstract][Full Text] [Related]
42. Vismodegib: a promising drug in the treatment of basal cell carcinomas.
Dirix L; Rutten A
Future Oncol; 2012 Aug; 8(8):915-28. PubMed ID: 22894666
[TBL] [Abstract][Full Text] [Related]
43. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications.
Yang L; Xie G; Fan Q; Xie J
Oncogene; 2010 Jan; 29(4):469-81. PubMed ID: 19935712
[TBL] [Abstract][Full Text] [Related]
44. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
Danhof R; Lewis K; Brown M
Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
[TBL] [Abstract][Full Text] [Related]
45. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
[TBL] [Abstract][Full Text] [Related]
46. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review).
Katoh Y; Katoh M
Int J Mol Med; 2006 Dec; 18(6):1019-23. PubMed ID: 17089004
[TBL] [Abstract][Full Text] [Related]
47. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
48. From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots.
Dessinioti C; Antoniou C; Stratigos AJ
Br J Dermatol; 2017 Dec; 177(6):1485-1494. PubMed ID: 28626889
[TBL] [Abstract][Full Text] [Related]
49. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
Gould A; Missailidis S
Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
[TBL] [Abstract][Full Text] [Related]
50. ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.
Kebenko M; Drenckhan A; Gros SJ; Jücker M; Grabinski N; Ewald F; Grottke A; Schultze A; Izbicki JR; Bokemeyer C; Wellbrock J; Fiedler W
Cell Signal; 2015 Feb; 27(2):373-81. PubMed ID: 25435423
[TBL] [Abstract][Full Text] [Related]
51. Current trends in Hedgehog signaling pathway inhibition by small molecules.
Ghirga F; Mori M; Infante P
Bioorg Med Chem Lett; 2018 Oct; 28(19):3131-3140. PubMed ID: 30177379
[TBL] [Abstract][Full Text] [Related]
52. Hedgehog signaling pathway as a potential target in the treatment of advanced gastric cancer.
Lee DH; Lee SY; Oh SC
Tumour Biol; 2017 Jun; 39(6):1010428317692266. PubMed ID: 28621241
[TBL] [Abstract][Full Text] [Related]
53. Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia.
Katagiri S; Tauchi T; Okabe S; Minami Y; Kimura S; Maekawa T; Naoe T; Ohyashiki K
Clin Cancer Res; 2013 Mar; 19(6):1422-32. PubMed ID: 23319824
[TBL] [Abstract][Full Text] [Related]
54. Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy.
Feng Z; Zhu S; Li W; Yao M; Song H; Wang RB
Eur J Med Chem; 2022 Dec; 244():114867. PubMed ID: 36332550
[TBL] [Abstract][Full Text] [Related]
55. Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma.
Manzella G; Schäfer BW
Curr Drug Targets; 2016; 17(11):1228-34. PubMed ID: 25944015
[TBL] [Abstract][Full Text] [Related]
56. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
[TBL] [Abstract][Full Text] [Related]
57. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
58. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.
Katoh Y; Katoh M
Curr Mol Med; 2009 Sep; 9(7):873-86. PubMed ID: 19860666
[TBL] [Abstract][Full Text] [Related]
59. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.
Gutzmer R; Solomon JA
Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of the Hedgehog pathway in lung cancer.
Dimou A; Bamias A; Gogas H; Syrigos K
Lung Cancer; 2019 Jul; 133():56-61. PubMed ID: 31200829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
